×




Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

Case Study SWOT Analysis Solution

Case Study Description of Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B)


Supplements the (A) case.

Authors :: Mary Gentile, Sarah B. Gant

Topics :: Leadership & Managing People

Tags :: Diversity, Downsizing, Leadership, Personnel policies, SWOT Analysis, SWOT Matrix, TOWS, Weighted SWOT Analysis

Swot Analysis of "Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B)" written by Mary Gentile, Sarah B. Gant includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Landgraf Kurt facing as an external strategic factors. Some of the topics covered in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) case study are - Strategic Management Strategies, Diversity, Downsizing, Leadership, Personnel policies and Leadership & Managing People.


Some of the macro environment factors that can be used to understand the Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) casestudy better are - – increasing transportation and logistics costs, wage bills are increasing, supply chains are disrupted by pandemic , technology disruption, challanges to central banks by blockchain based private currencies, increasing inequality as vast percentage of new income is going to the top 1%, competitive advantages are harder to sustain because of technology dispersion, geopolitical disruptions, increasing commodity prices, etc



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now







Introduction to SWOT Analysis of Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B)


SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Landgraf Kurt, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Landgraf Kurt operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.




SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix


SWOT analysis of Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) can be done for the following purposes –
1. Strategic planning using facts provided in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) case study
2. Improving business portfolio management of Landgraf Kurt
3. Assessing feasibility of the new initiative in Leadership & Managing People field.
4. Making a Leadership & Managing People topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Landgraf Kurt




Strengths Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of Landgraf Kurt in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) Harvard Business Review case study are -

Learning organization

- Landgraf Kurt is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Landgraf Kurt is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) Harvard Business Review case study emphasize – knowledge, initiative, and innovation.

Highly skilled collaborators

– Landgraf Kurt has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive segment. Secondly the value chain collaborators of the firm in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) HBR case study have helped the firm to develop new products and bring them quickly to the marketplace.

Successful track record of launching new products

– Landgraf Kurt has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Landgraf Kurt has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.

Strong track record of project management

– Landgraf Kurt is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

Innovation driven organization

– Landgraf Kurt is one of the most innovative firm in sector. Manager in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) Harvard Business Review case study can use Clayton Christensen Disruptive Innovation strategies to further increase the scale of innovtions in the organization.

Diverse revenue streams

– Landgraf Kurt is present in almost all the verticals within the industry. This has provided firm in Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) case study a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.

Organizational Resilience of Landgraf Kurt

– The covid-19 pandemic has put organizational resilience at the centre of everthing that Landgraf Kurt does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.

Effective Research and Development (R&D)

– Landgraf Kurt has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in, as mentioned in case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) - staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.

Digital Transformation in Leadership & Managing People segment

- digital transformation varies from industry to industry. For Landgraf Kurt digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Landgraf Kurt has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.

Operational resilience

– The operational resilience strategy in the Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) Harvard Business Review case study comprises – understanding the underlying the factors in the industry, building diversified operations across different geographies so that disruption in one part of the world doesn’t impact the overall performance of the firm, and integrating the various business operations and processes through its digital transformation drive.

Low bargaining power of suppliers

– Suppliers of Landgraf Kurt in the sector have low bargaining power. Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Landgraf Kurt to manage not only supply disruptions but also source products at highly competitive prices.

Cross disciplinary teams

– Horizontal connected teams at the Landgraf Kurt are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.






Weaknesses Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) are -

Slow to strategic competitive environment developments

– As Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) HBR case study mentions - Landgraf Kurt takes time to assess the upcoming competitions. This has led to missing out on atleast 2-3 big opportunities in the industry in last five years.

Workers concerns about automation

– As automation is fast increasing in the segment, Landgraf Kurt needs to come up with a strategy to reduce the workers concern regarding automation. Without a clear strategy, it could lead to disruption and uncertainty within the organization.

High cash cycle compare to competitors

Landgraf Kurt has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.

Interest costs

– Compare to the competition, Landgraf Kurt has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.

High dependence on existing supply chain

– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Landgraf Kurt supply chain. Even after few cautionary changes mentioned in the HBR case study - Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B), it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Landgraf Kurt vulnerable to further global disruptions in South East Asia.

Ability to respond to the competition

– As the decision making is very deliberative, highlighted in the case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B), in the dynamic environment Landgraf Kurt has struggled to respond to the nimble upstart competition. Landgraf Kurt has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.

Employees’ incomplete understanding of strategy

– From the instances in the HBR case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B), it seems that the employees of Landgraf Kurt don’t have comprehensive understanding of the firm’s strategy. This is reflected in number of promotional campaigns over the last few years that had mixed messaging and competing priorities. Some of the strategic activities and services promoted in the promotional campaigns were not consistent with the organization’s strategy.

High bargaining power of channel partners

– Because of the regulatory requirements, Mary Gentile, Sarah B. Gant suggests that, Landgraf Kurt is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.

Need for greater diversity

– Landgraf Kurt has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.

High dependence on star products

– The top 2 products and services of the firm as mentioned in the Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) HBR case study still accounts for major business revenue. This dependence on star products in has resulted into insufficient focus on developing new products, even though Landgraf Kurt has relatively successful track record of launching new products.

Aligning sales with marketing

– It come across in the case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) that the firm needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department in the case Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) can leverage the sales team experience to cultivate customer relationships as Landgraf Kurt is planning to shift buying processes online.




Opportunities Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The opportunities highlighted in the Harvard Business Review case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) are -

Finding new ways to collaborate

– Covid-19 has not only transformed business models of companies in Leadership & Managing People industry, but it has also influenced the consumer preferences. Landgraf Kurt can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.

Reconfiguring business model

– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Landgraf Kurt to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.

Buying journey improvements

– Landgraf Kurt can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) suggest that firm can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.

Use of Bitcoin and other crypto currencies for transactions

– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Landgraf Kurt in the consumer business. Now Landgraf Kurt can target international markets with far fewer capital restrictions requirements than the existing system.

Changes in consumer behavior post Covid-19

– Consumer behavior has changed in the Leadership & Managing People industry because of Covid-19 restrictions. Some of this behavior will stay once things get back to normal. Landgraf Kurt can take advantage of these changes in consumer behavior to build a far more efficient business model. For example consumer regular ordering of products can reduce both last mile delivery costs and market penetration costs. Landgraf Kurt can further use this consumer data to build better customer loyalty, provide better products and service collection, and improve the value proposition in inflationary times.

Identify volunteer opportunities

– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Landgraf Kurt can explore opportunities that can attract volunteers and are consistent with its mission and vision.

Learning at scale

– Online learning technologies has now opened space for Landgraf Kurt to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.

Low interest rates

– Even though inflation is raising its head in most developed economies, Landgraf Kurt can still utilize the low interest rates to borrow money for capital investment. Secondly it can also use the increase of government spending in infrastructure projects to get new business.

Developing new processes and practices

– Landgraf Kurt can develop new processes and procedures in Leadership & Managing People industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.

Manufacturing automation

– Landgraf Kurt can use the latest technology developments to improve its manufacturing and designing process in Leadership & Managing People segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.

Loyalty marketing

– Landgraf Kurt has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.

Creating value in data economy

– The success of analytics program of Landgraf Kurt has opened avenues for new revenue streams for the organization in the industry. This can help Landgraf Kurt to build a more holistic ecosystem as suggested in the Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) case study. Landgraf Kurt can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.

Building a culture of innovation

– managers at Landgraf Kurt can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Leadership & Managing People segment.




Threats Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The threats mentioned in the HBR case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) are -

Shortening product life cycle

– it is one of the major threat that Landgraf Kurt is facing in Leadership & Managing People sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.

High level of anxiety and lack of motivation

– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Landgraf Kurt needs to understand the core reasons impacting the Leadership & Managing People industry. This will help it in building a better workplace.

Learning curve for new practices

– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B), Landgraf Kurt may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Leadership & Managing People .

Instability in the European markets

– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Landgraf Kurt will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.

Technology acceleration in Forth Industrial Revolution

– Landgraf Kurt has witnessed rapid integration of technology during Covid-19 in the Leadership & Managing People industry. As one of the leading players in the industry, Landgraf Kurt needs to keep up with the evolution of technology in the Leadership & Managing People sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.

Technology disruption because of hacks, piracy etc

– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.

Aging population

– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Landgraf Kurt.

Backlash against dominant players

– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Landgraf Kurt business can come under increasing regulations regarding data privacy, data security, etc.

New competition

– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Landgraf Kurt in the Leadership & Managing People sector and impact the bottomline of the organization.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry in the industry are lowering. It can presents Landgraf Kurt with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.

Easy access to finance

– Easy access to finance in Leadership & Managing People field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Landgraf Kurt can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.

Environmental challenges

– Landgraf Kurt needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Landgraf Kurt can take advantage of this fund but it will also bring new competitors in the Leadership & Managing People industry.




Weighted SWOT Analysis of Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) Template, Example


Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of the case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of the Harvard case study Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (B) is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Landgraf Kurt needs to make to build a sustainable competitive advantage.



--- ---

Julie Hallman at the Falaise Foundation SWOT Analysis / TOWS Matrix

Ann C. Frost, Tony S. Frost, Mary Gillett , Leadership & Managing People


Brand W: Strategizing for Omni-Channel Retail SWOT Analysis / TOWS Matrix

Jones Mathew, Banasree Dey, Sandeep Puri , Sales & Marketing


Managing Change in Operations SWOT Analysis / TOWS Matrix

Robert D. Landel, Rebecca Oliver , Organizational Development


Broadband and Video Games: Playing and Winning Together SWOT Analysis / TOWS Matrix

Stephen P. Bradley, Nancy Bartlett , Innovation & Entrepreneurship


Frank Addante, Serial Entrepreneur SWOT Analysis / TOWS Matrix

Noam Wasserman, Antony Uy , Innovation & Entrepreneurship


American University of Beirut Medical Center: Patient Transport SWOT Analysis / TOWS Matrix

Lina Daouk-Oyry, Dania Baba, Line Reda, Neil Yorke-Smith , Global Business


Putting Artificial Intelligence to Work SWOT Analysis / TOWS Matrix

Philipp Gerbert, Martin Hecker, Sebastian Steinhauser , Strategy & Execution


Deferred Compensation SWOT Analysis / TOWS Matrix

Henry B. Reiling, Mark R. Pollard , Finance & Accounting


Charity or Bribery SWOT Analysis / TOWS Matrix

Eugene Soltes, Brian Tilley , Leadership & Managing People